Intelligent Bio Solutions Inc. INBS
1.70
(0.01)
(0.58%)
as of 25 Sep
- Market cap
- $5.7M
- P/E
- 0.0×
Follow INBS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (306.76%) | (169.60%) | (149.66%) | (231.78%) |
+8 more TTM periods Free account |
|
| (123.13%) | (95.01%) | (85.77%) | (99.85%) | ||
ROIC |
(606.86%) | (387.05%) | (69.74%) | (387.48%) | |
Return on Tangible Assets |
(504.77%) | (213.05%) | (153.26%) | 3,551.01% | |
Average Days of Receivables |
143.34 | 137.10 | 1,074.54 | 182.05 | |
Free Cash Flow per Share |
(8.30) | (7.06) | (10.21) | (11.86) | |
Free Cash Flow |
(12.22) | (11.26) | (9.71) | (10.14) | |
Capital Expenditures |
(0.29) | (0.31) | (0.33) | — | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(128.48%) | (70.16%) | (80.65%) | (199.27%) | |
Accounts Receivable Turnover |
2.82 | 3.11 | 0.64 | 2.30 | |
Accounts Payable Turnover |
0.50 | 0.83 | 0.72 | 0.64 | |
Inventory Turnover |
4.11 | 3.22 | 2.98 | 2.74 | |
Average Days of Payables |
696.28 | 642.88 | 807.42 | 777.73 | |
Days of Inventory on Hand |
70.57 | 105.65 | 111.83 | 122.37 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
79.98% | 64.50% | 55.37% | 58.75% | |
Selling, General and Administrative Expense of Revenue |
249.15% | 264.81% | 288.52% | 292.50% | |
Share Based Compensation of Revenue |
4.63% | 2.85% | 2.77% | 1.46% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.96 | 0.94 | 0.83 | 0.93 | |
Depreciation/Fixed assets |
3.95 | 3.77 | 3.68 | 4.51 | |
Capex/Depreciation |
(0.25) | (0.26) | (0.28) | 0.00 | |
Revenue per Share |
2.86 | 2.42 | 3.70 | 3.85 | |
Operating CF per Share |
(8.10) | (6.87) | (9.86) | (11.86) | |
Capex per Share |
(0.20) | (0.19) | (0.35) | 0.00 | |
Capex to Sales |
0.07 | 0.08 | 0.09 | 0.00 | |
Net Profit Margin |
(294.91%) | (301.47%) | (320.82%) | (330.08%) |
Columns are period end dates